News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,780 Results
Type
Article (13643)
Company Profile (108)
Press Release (249029)
Section
Business (87972)
Career Advice (464)
Deals (15333)
Drug Delivery (64)
Drug Development (36554)
Employer Resources (49)
FDA (6269)
Job Trends (6189)
News (150084)
Policy (14014)
Tag
Academia (435)
Alliances (23169)
Alzheimer's disease (371)
Approvals (6280)
Artificial intelligence (73)
Bankruptcy (144)
Best Places to Work (4356)
Breast cancer (64)
Cancer (448)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (61)
Clinical research (30622)
Collaboration (232)
Compensation (96)
COVID-19 (751)
C-suite (76)
Data (446)
Diabetes (64)
Diagnostics (1249)
Drug discovery (45)
Drug pricing (59)
Earnings (31629)
Events (37005)
Executive appointments (263)
FDA (6535)
Funding (153)
Gene therapy (72)
GLP-1 (314)
Government (1272)
Healthcare (3542)
Infectious disease (773)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5848)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3416)
Lung cancer (64)
Manufacturing (113)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9588)
Metabolic disorders (199)
Neuroscience (494)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (547)
Obesity (119)
Opinion (113)
Patents (70)
People (28642)
Pharmaceutical (67)
Phase I (7973)
Phase II (12945)
Phase III (11631)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (115)
Real estate (2631)
Regulatory (9926)
Research institute (563)
Resumes & cover letters (55)
Southern California (532)
Startups (1625)
United States (5332)
Vaccines (120)
Weight loss (86)
Date
Today (47)
Last 7 days (146)
Last 30 days (723)
Last 365 days (12362)
2025 (629)
2024 (12507)
2023 (14247)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (45)
Asia (19935)
Australia (2573)
California (1278)
Canada (718)
China (169)
Colorado (51)
Connecticut (54)
Europe (39013)
Florida (213)
Illinois (145)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (188)
Massachusetts (1109)
Minnesota (70)
New Jersey (528)
New York (358)
North Carolina (316)
Northern California (547)
Pennsylvania (337)
South America (500)
Southern California (532)
Texas (169)
Virginia (49)
Washington State (85)
262,780 Results for "supernus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Supernus Pharmaceuticals, Inc. announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:30 p.m. ET at the Marriott Marquis Hotel in New York City.
May 30, 2024
·
4 min read
Press Releases
Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
4 min read
Press Releases
Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 26, 2024
·
4 min read
BioCapital
Supernus to Participate in Two Upcoming March 2024 Investor Conferences
Supernus Pharmaceuticals, Inc. announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences:
March 6, 2024
·
4 min read
Business
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
August 28, 2024
·
3 min read
Business
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Supernus Pharmaceuticals, Inc. announced that it expects to report financial and business results for the first quarter of 2024 after the market closes on Wednesday, May 8, 2024.
April 24, 2024
·
1 min read
BioCapital
Supernus Provides Regulatory Update for SPN-830
Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced a regulatory update for SPN-830.
April 8, 2024
·
4 min read
Business
Supernus Announces First Quarter 2024 Financial Results
Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced financial results for the first quarter of 2024 and associated Company developments.
May 8, 2024
·
16 min read
Press Releases
Supernus Announces Third Quarter 2024 Financial Results
November 4, 2024
·
19 min read
Business
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
September 19, 2024
·
3 min read
1 of 26,278
Next
